Page last updated: 2024-12-07
genkwadaphnin
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Description
genkwadaphnin: from Daphne genkwa; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Related Flora
Flora | Rank | Flora Definition | Family | Family Definition |
---|---|---|---|---|
Daphne | genus | A plant genus of the family THYMELAEACEAE. They are evergreen shrubs much cultivated in garden borders and rock gardens in mild climates. Members contain mezerein, flavonoids, and COUMARINS such as daphnetin and daphnin.[MeSH] | Thymelaeaceae | A plant family of the order Myrtales, subclass Rosidae, class Magnoliopsida. They are mainly trees and shrubs. Many members contain mucilage and COUMARINS.[MeSH] |
Cross-References
ID Source | ID |
---|---|
PubMed CID | 124210 |
MeSH ID | M0110950 |
Synonyms (9)
Synonym |
---|
brn 1675425 |
12-beta-(benzoyloxy)daphnetoxin |
daphnetoxin, 12-(benzoyloxy)-, (12beta)- |
daphnetoxin, 12-(benzoyloxy)-, (12-beta)- |
genkwadaphnin |
55073-32-0 |
DTXSID10970422 |
5,5a-dihydroxy-4a-(hydroxymethyl)-7,9-dimethyl-6-oxo-2-phenyl-10a-(prop-1-en-2-yl)-3a,3c,4a,5,5a,6,8a,9,10,10a-decahydro-2h,3bh-2,8b-epoxyoxireno[6,7]azuleno[5,4-e][1,3]benzodioxol-10-yl benzoate |
[(1r,2r,6s,7s,8r,10s,11s,12r,14r,16s,17r,18r)-6,7-dihydroxy-8-(hydroxymethyl)-4,18-dimethyl-5-oxo-14-phenyl-16-prop-1-en-2-yl-9,13,15,19-tetraoxahexacyclo[12.4.1.01,11.02,6.08,10.012,16]nonadec-3-en-17-yl] benzoate |
Research Excerpts
Overview
Genkwadaphnin is a daphnane diterpene ester molecule isolated from the flower buds of Daphne genkwa.
Excerpt | Reference | Relevance |
---|---|---|
"Genkwadaphnin (GD) is a daphnane diterpene isolated from the flower buds of Daphne genkwa Siebold et Zuccarini (Thymelaeaceae)." | ( Genkwadaphnin inhibits growth and invasion in hepatocellular carcinoma by blocking DHCR24-mediated cholesterol biosynthesis and lipid rafts formation. Cui, W; Guo, L; Li, F; Qiu, X; Ren, Y; Song, S; Wu, J, 2020) | 2.72 |
"Genkwadaphnin is a daphnane diterpene ester molecule isolated from the flower buds of Daphne genkwa. " | ( Genkwadaphnin induces reactive oxygen species (ROS)-mediated apoptosis of squamous cell carcinoma (SCC) cells. Choi, DK; Kim, CD; Kim, JW; Kim, SJ; Lee, JH; Li, XM; Li, ZJ; Piao, YJ; Sohn, KC, 2014) | 3.29 |
Treatment
Genkwadaphnin treatment increased phosphorylation of c-Jun N-terminal kinase. ATDC5 cells also stained more intensely with Alcian blue than control cells. This suggests greater synthesis of matrix proteoglycans in the former.
Excerpt | Reference | Relevance |
---|---|---|
"Genkwadaphnin treatment increased phosphorylation of c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (MAPK)." | ( Genkwadaphnin induces reactive oxygen species (ROS)-mediated apoptosis of squamous cell carcinoma (SCC) cells. Choi, DK; Kim, CD; Kim, JW; Kim, SJ; Lee, JH; Li, XM; Li, ZJ; Piao, YJ; Sohn, KC, 2014) | 2.57 |
"Genkwadaphnin treated ATDC5 cells also stained more intensely with Alcian blue than control cells, suggesting greater synthesis of matrix proteoglycans in the former." | ( Stimulation of chondrogenesis in ATDC5 chondroprogenitor cells and hypertrophy in mouse by Genkwadaphnin. Choi, HJ; Lee, HK; Nepal, M; Oh, SR; Park, YR; Soh, Y, 2011) | 1.31 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (12)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 3 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (16.67) | 29.6817 |
2010's | 6 (50.00) | 24.3611 |
2020's | 1 (8.33) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 12 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |